Brett Sandercock Resmed Inc (RSMDF) insider trading activity

Brett Sandercock is Chief Financial Officer of RESMED INC. Currently has a direct ownership of 94,864 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on Nov 08, 2024, when has been sold 1,000 shares (ResMed Common Stock) at a price of $249.0 per share, resulting in proceeds of $249,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 94.9K

3.01% 3M change

1.1% 12M change

Total Value Held $0

Brett Sandercock Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 08 2024	SELL Open market or private sale	$249,000 $249.0 p/Share	1,000 Reduced 1.04%	94,864 ResMed Common Stock
Oct 08 2024	SELL Open market or private sale	$233,470 $233.47 p/Share	1,000 Reduced 1.03%	95,812 ResMed Common Stock
Sep 09 2024	SELL Open market or private sale	$246,420 $246.42 p/Share	1,000 Reduced 1.02%	96,812 ResMed Common Stock
Aug 15 2024	BUY Grant, award, or other acquisition	-	8,756 Added 8.22%	97,812 ResMed Common Stock
Aug 08 2024	SELL Open market or private sale	$212,160 $212.16 p/Share	1,000 Reduced 1.11%	89,056 ResMed Common Stock
Jul 08 2024	SELL Open market or private sale	$194,350 $194.35 p/Share	1,000 Reduced 1.1%	90,056 ResMed Common Stock
Jun 10 2024	SELL Open market or private sale	$209,810 $209.81 p/Share	1,000 Reduced 1.09%	91,056 ResMed Common Stock
May 08 2024	SELL Open market or private sale	$2,747,810 $211.37 p/Share	13,000 Reduced 12.37%	92,056 ResMed Common Stock
May 08 2024	BUY Exercise of conversion of derivative security	$1,219,680 $101.64 p/Share	12,000 Added 10.25%	105,056 ResMed Common Stock
Nov 27 2023	SELL Open market or private sale	$457,860 $152.62 p/Share	3,000 Reduced 3.13%	92,962 ResMed Common Stock
Aug 17 2023	BUY Grant, award, or other acquisition	-	4,972 Added 4.93%	95,915 ResMed Common Stock
May 10 2023	SELL Open market or private sale	$2,931,376 $233.13 p/Share	12,574 Reduced 12.15%	90,942 ResMed Common Stock
May 09 2023	SELL Open market or private sale	$795,003 $232.05 p/Share	3,426 Reduced 3.2%	103,516 ResMed Common Stock
Feb 17 2023	SELL Open market or private sale	$2,152,200 $215.22 p/Share	10,000 Reduced 8.56%	106,880 ResMed Common Stock
Feb 13 2023	SELL Open market or private sale	$860,000 $215.0 p/Share	4,000 Reduced 3.31%	116,880 ResMed Common Stock
Nov 23 2022	BUY Grant, award, or other acquisition	-	14,577 Added 10.76%	120,880 ResMed Common Stock
Nov 07 2022	SELL Open market or private sale	$848,080 $212.02 p/Share	4,000 Reduced 3.63%	106,303 ResMed Common Stock
Aug 18 2022	BUY Grant, award, or other acquisition	-	3,847 Added 3.37%	110,273 ResMed Common Stock
Aug 10 2022	SELL Open market or private sale	$601,650 $240.66 p/Share	2,500 Reduced 2.3%	106,426 ResMed Common Stock
Aug 10 2022	BUY Exercise of conversion of derivative security	$144,400 $57.76 p/Share	2,500 Added 2.24%	108,926 ResMed Common Stock
Jul 22 2022	SELL Open market or private sale	$1,762,500 $235.0 p/Share	7,500 Reduced 6.58%	106,426 ResMed Common Stock
Jul 22 2022	BUY Exercise of conversion of derivative security	$433,200 $57.76 p/Share	7,500 Added 6.18%	113,926 ResMed Common Stock
Apr 11 2022	SELL Open market or private sale	$617,500 $247.0 p/Share	2,500 Reduced 2.3%	106,354 ResMed Common Stock
Apr 11 2022	BUY Exercise of conversion of derivative security	$144,400 $57.76 p/Share	2,500 Added 2.25%	108,854 ResMed Common Stock
Mar 10 2022	SELL Open market or private sale	$603,225 $241.29 p/Share	2,500 Reduced 2.3%	106,354 ResMed Common Stock

Brett Sandercock

Chief Financial Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RSMDF shares.

Notify only if

Value

Insider Trading

Get notified when an Resmed Inc insider buys or sells RSMDF shares.

Notify only if

Operation

Value

Type

News

Receive news related to RESMED INC

Track Activities on RSMDF

Account